Literature DB >> 1279102

Assembly of conformation-dependent neutralizing domains on glycoprotein B of human cytomegalovirus.

I Qadri1, D Navarro, P Paz, L Pereira.   

Abstract

We analysed the antigenic properties of human cytomegalovirus (CMV) glycoprotein B (gB) by constructing a set of deletion derivatives lacking different portions of the carboxy terminus and reacting them with a panel of monoclonal antibodies with neutralizing activity. We found that two novel antigenic domains that bind neutralizing antibodies were assembled on truncated forms of gB, one in the amino-terminal half and one that spans the midregion of the molecule. Assembly of the conformation-dependent epitopes occurred independently of residues in the carboxy-terminal half of the molecule and did not depend on proteolytic cleavage of the molecule between amino acids 460 and 461. Ten antibodies recognized a derivative with 447 amino-terminal residues; their failure to recognize a derivative 411 residues long suggested that the amino acids required for assembly of these epitopes either were incorrectly folded, or had been totally or partially deleted in this derivative. Epitopes for three antibodies with complement-independent neutralizing activity were assembled when amino acids from the midregion of gB between residues 447 and 476 were present. Two other antigenic domains were formed by the addition of residues 476 to 618 and 619 to 645 from the carboxy-terminal half of gB. Our results underscore the importance of conformation in the antigenic structure and functional properties of both the amino- and carboxy-terminal portions of gB.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1279102     DOI: 10.1099/0022-1317-73-11-2913

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  An acidic cluster in the cytosolic domain of human cytomegalovirus glycoprotein B is a signal for endocytosis from the plasma membrane.

Authors:  S Tugizov; E Maidji; J Xiao; L Pereira
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Human cytomegalovirus transmission from the uterus to the placenta correlates with the presence of pathogenic bacteria and maternal immunity.

Authors:  Lenore Pereira; Ekaterina Maidji; Susan McDonagh; Olga Genbacev; Susan Fisher
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Sustained expression of human cytomegalovirus glycoprotein B (UL55) in the seeds of homozygous rice plants.

Authors:  Eilleen S Tackaberry; Fiona A Prior; Karen Rowlandson; Monika Tocchi; Jelica Mehic; Suzanne Porter; Mike Walsh; Mark R Schleiss; Peter R Ganz; Ravinder K Sardana; Illimar Altosaar; Anil K Dudani
Journal:  Mol Biotechnol       Date:  2008-04-16       Impact factor: 2.695

4.  Anti-idiotypic mimicry of a neutralizing epitope on the glycoprotein B complex of human cytomegalovirus.

Authors:  E S Tackaberry; J Hamel; Y Larose; B R Brodeur
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

5.  Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells.

Authors:  S Tugizov; E Maidji; J Xiao; Z Zheng; L Pereira
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

6.  The human cytomegalovirus UL55 (gB) and UL75 (gH) glycoprotein ligands initiate the rapid activation of Sp1 and NF-kappaB during infection.

Authors:  A D Yurochko; E S Hwang; L Rasmussen; S Keay; L Pereira; E S Huang
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

7.  Maternal antibodies enhance or prevent cytomegalovirus infection in the placenta by neonatal Fc receptor-mediated transcytosis.

Authors:  Ekaterina Maidji; Susan McDonagh; Olga Genbacev; Takako Tabata; Lenore Pereira
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

8.  Mutations in the carboxyl-terminal hydrophobic sequence of human cytomegalovirus glycoprotein B alter transport and protein chaperone binding.

Authors:  Z Zheng; E Maidji; S Tugizov; L Pereira
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

9.  Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.

Authors:  William J Britt; Michael A Jarvis; Derek D Drummond; Michael Mach
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

10.  Cytomegalovirus-specific, high-avidity IgG with neutralizing activity in maternal circulation enriched in the fetal bloodstream.

Authors:  Naoki Nozawa; June Fang-Hoover; Takako Tabata; Ekaterina Maidji; Lenore Pereira
Journal:  J Clin Virol       Date:  2009-10-24       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.